« back to directory

Company Profile



About Mesoblast

Mesoblast is a world leader in developing innovative cellular medicines. Their clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.

Mesoblast is focused on five core strategic imperatives:

  • creating clinically differentiated products
  • bringing late-stage products to market
  • enabling manufacturing scale-up to meet demands
  • establishing a culture of shared leadership and accountability, and
  • building strategic partnerships

The Mesoblast proprietary cell technology platform, which is based on mesenchymal lineage adult stem cells (MLCs), has been applied to build a highly advanced cell-based product portfolio, and has the potential to address multiple conditions with significant unmet medical needs.